Mind Medicine Inc (MNMD)

Feb 01, 2025

HC Wainwright Reiterates "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat

Feb 01, 2025

Feb 01, 2025

Leerink Partnrs Has Bearish Outlook for MNMD Q4 Earnings - MarketBeat

Feb 01, 2025

Jan 31, 2025

symbol__ Stock Quote Price and Forecast - CNN

Jan 31, 2025

Jan 31, 2025

Equities Analysts Set Expectations for MNMD Q1 Earnings - Defense World

Jan 31, 2025

Jan 30, 2025

MindMed Initiates Second Phase 3 Study of MM120 for Anxiety - TipRanks

Jan 30, 2025

Jan 30, 2025

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's Why - MarketBeat

Jan 30, 2025

Jan 30, 2025

What is Leerink Partnrs' Forecast for MNMD Q1 Earnings? - MarketBeat

Jan 30, 2025

Jan 30, 2025

MindMed launches phase 3 trial for anxiety treatment - Investing.com

Jan 30, 2025

Jan 30, 2025

MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder - StreetInsider.com

Jan 30, 2025

Jan 30, 2025

Mindmed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of Mm120 in Generalized Anxiety Disorder - Marketscreener.com

Jan 30, 2025

Jan 30, 2025

(MNMD) Trading Signals - Stock Traders Daily

Jan 30, 2025

Jan 29, 2025

MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD) - Seeking Alpha

Jan 29, 2025

Jan 29, 2025

Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish - MSN

Jan 29, 2025

Jan 29, 2025

Mind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Evercore ISI - MarketBeat

Jan 29, 2025

Jan 28, 2025

Evercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform Recommendation - MSN

Jan 28, 2025

Jan 28, 2025

Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated by Analysts at Evercore ISI - MarketBeat

Jan 28, 2025

Jan 28, 2025

This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Jan 28, 2025

Jan 22, 2025

5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.

Jan 22, 2025

Jan 20, 2025

Why Mind Medicine Stock Is Soaring Today - MSN

Jan 20, 2025

Jan 19, 2025

Where are the Opportunities in (MNMD) - Stock Traders Daily

Jan 19, 2025

Jan 18, 2025

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4%What's Next? - MarketBeat

Jan 18, 2025

Jan 18, 2025

Wealth Enhancement Advisory Services LLC Acquires 2,230 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World

Jan 18, 2025

Jan 16, 2025

Barclays PLC Has $775,000 Stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat

Jan 16, 2025

Jan 15, 2025

MindMed gives more detail to investors in latest presentation - Green Market Report

Jan 15, 2025

Jan 10, 2025

Psychedelic drug developer Lykos could get lifeline from former Tesla board member - Seeking Alpha

Jan 10, 2025

Jan 10, 2025

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Jan 10, 2025

Jan 08, 2025

Mind Medicine Inc Reports Topline Data from Phase 1 Trial of MM-110 in Development for Treatment of Opioid Withdrawal - Marketscreener.com

Jan 08, 2025

Jan 07, 2025

Institutional investors are Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) biggest bettors and were rewarded after last week's US$73m market cap gain - Simply Wall St

Jan 07, 2025

Jan 07, 2025

MindMed (MNMD) Stock Surges on Psychedelic Mushroom Developments - GuruFocus.com

Jan 07, 2025

Jan 06, 2025

Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 7.8% HigherShould You Buy? - MarketBeat

Jan 06, 2025

Jan 03, 2025

Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.7%Should You Sell? - MarketBeat

Jan 03, 2025

Jan 02, 2025

MindMed to Participate in the Jefferies Global Healthcare Conference - Marketscreener.com

Jan 02, 2025

Jan 02, 2025

Geode Capital Management LLC Has $9.55 Million Stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat

Jan 02, 2025

Jan 01, 2025

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Shares Purchased by Barclays PLC - MarketBeat

Jan 01, 2025

Dec 29, 2024

(MNMD) Investment Analysis - Stock Traders Daily

Dec 29, 2024

Dec 28, 2024

Mind Medicine's chief medical officer sells shares worth $49,357 - Investing.com India

Dec 28, 2024

Dec 28, 2024

Mind Medicine's chief medical officer sells shares worth $49,357 By Investing.com - Investing.com Australia

Dec 28, 2024

Dec 27, 2024

Mind Medicine CEO Robert Barrow sells shares worth $141,957 By Investing.com - Investing.com Nigeria

Dec 27, 2024

Dec 27, 2024

Mind Medicine's chief legal officer sells $33,576 in stock - Investing.com India

Dec 27, 2024

Dec 27, 2024

Mind Medicine CEO Robert Barrow sells shares worth $141,957 - Investing.com India

Dec 27, 2024

Dec 27, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) CEO Sells $141,957.58 in Stock - MarketBeat

Dec 27, 2024

Dec 27, 2024

Carrie Liao Sells 2,273 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock - MarketBeat

Dec 27, 2024

Dec 27, 2024

Mind medicine's chief accounting officer sells shares for $16,888 By Investing.com - Investing.com Canada

Dec 27, 2024

Dec 27, 2024

Mind Medicine’s chief medical officer sells shares worth $49,357 By Investing.com - Investing.com Nigeria

Dec 27, 2024

Dec 27, 2024

Mind Medicine's chief legal officer sells $33,576 in stock By Investing.com - Investing.com South Africa

Dec 27, 2024

Dec 27, 2024

Mind Medicine’s chief legal officer sells $33,576 in stock By Investing.com - Investing.com Nigeria

Dec 27, 2024